Meeting
2024 ASCO Annual Meeting
A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pretreated advanced biliary tract cancer: Efficacy and safety analysis (BOLD-100-001).
Authors
Grainne M. O'Kane
Trinity St. James’s Cancer Institute, Dublin, Ireland
Grainne M. O'Kane , Do-Youn Oh , Jennifer Spratlin , Sun Young Rha , Elena Elimova , Petr Kavan , Rachel Anne Goodwin , Yongjun Cha , Seung Tae Kim , E. Russell McAllister , Michelle Jones , Malcolm Snow , Yasmin Lemmerick , Gonzalo Spera , Jim Pankovich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer - Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT04421820
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 4115)
DOI
10.1200/JCO.2024.42.16_suppl.4115
Abstract #
4115
Poster Bd #
95
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
BOLD-100-001 (TRIO039): A phase 1b/2a study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced gastric and biliary tract cancer: Efficacy and safety analysis.
First Author: Grainne M. O'Kane
Poster
2017 Gastrointestinal Cancers Symposium
Outcomes of second line treatment in patients with advanced and metastatic biliary cancers.
First Author: Gustavo Figueiredo Marcondes Westin
Poster
2012 ASCO Annual Meeting
Tolerability and efficacy of a biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin regimen (TFOX) in previously advanced metastatic gastric and oesogastric junction (AGC) adenocarcinoma.
First Author: Simon Pernot
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.
First Author: Vikas S. Ostwal